Fluorouracil Roche is a drug from the group of antimetabolites. It is used in the treatment of malignant tumors of the esophagus, stomach, intestines and mammary glands.
The drug is produced by Hoffman LaRoche (Switzerland), which is one of the world leaders in the field of oncology. The drug is registered in Russia under the trade name Fluorourace L.